slide.title

A unique culture delivering exceptional solutions

A unique culture delivering exceptional solutions A unique culture delivering exceptional solutions
Home /

A unique culture delivering exceptional solutions

50 years ago, our late founder and Chairman, Sir Allen McClay, pursued his vision of one company making a substantial contribution to healthcare across the globe and began the journey of Almac. Today, Allen’s vision and legacy continues to live on through our valued employees. Our unique culture, passionate people and constant drive for innovative solutions is at the heart of what we do and makes Almac a very special organization.

We are proud of our global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

Almac people continue to deliver this unique culture of unrivaled commitment to the long-term relationships we develop and nurture.

A culture of understanding.

A culture of exceptional solutions.

And as Almac now looks forward to continuing success alongside partners across the world, our guarantee to our employees, and our customers, is this…

We will be exceptional. Always.

Click here to learn more about our extensive range of integrated services across the drug product lifecycle.

50 Years of Successful Growth

2019

2019

Construction of Almac Group’s EU Campus in Dundalk, Ireland is complete

2019

2019

Almac Group opens MED-Lab exhibition in W5, Belfast, Northern Ireland

2019

Almac Group announces additional expansion of its Global Analytical Services Capability, investing significantly in additional laboratory space at its facility in Athlone, Ireland

2018

2018

Almac Group celebrate 50 years

2018

Almac Group turnover surpasses £500 million for first time

2018

2018

Almac Group expands with opening of £20 million Cold Chain Facility at its Global HQ in Craigavon, UK

2017

2017

Almac Group acquires BioClin Laboratories, Athlone, Ireland

2017

2017

Almac Group establishes European Campus in Dundalk, Ireland

2016

2016

Almac Group opens its new companion diagnostic development facility located in the Research Triangle region of North Carolina, USA

2015

2015

Almac Group confirms a £16 million investment to expand its Formulation and Analytical Development services to meet ongoing client demand in Loughborough, England

2015

2015

Almac Group acquires Arran Chemical Company, Athlone, Ireland

2014

2014

Almac Group opens its new Asia Pacific Headquarter facility in Singapore

2013

Almac Group opens its dedicated facility for Non-GMP formulation development

2013

2013

Almac Group opens its Commercial Packaging facility in Audubon, PA, USA

2011

2011

Almac Group opens its new North American Headquarter facility in Souderton, PA, USA

2010

2010

On 12 January, just months before the NAHQ is completed, Sir Allen McClay passes away – However, his vision lives on through his work and the commitment of the Almac Group

2008

2008

Almac Discovery, an independent company focused exclusively on the discovery and development of novel and innovative approaches to the treatment of cancer is established

2008

Almac Group invests $120M in its new North American Headquarters (NAHQ)

2006

2006

Allen McClay OBE, CBE becomes Sir Allen McClay when Prince Charles knights him at Buckingham Palace

2005

Almac Group opens dedicated facilities for GMP formulation development and biomarker discovery & development services

2004

2004

Almac Group acquires Peptide & Protein research facility in Elvingston, Scotland

2004

Allen McClay OBE, CBE announces the purchase of Galen Ltd, the UK based Ethical Pharmaceutical Products Sales and Marketing business

2003

Almac Group announces the acquisition of Pharmaceutical Manufacturing operations from Galen Holdings Plc

2003

Almac Group acquires its Biomarker Discovery & Development business

2003

2003

Almac Group opens its Global Headquarters in Craigavon, UK

2002

2002

Almac Group founded by Allen McClay OBE, CBE created from Galen Services businesses

2001

2001

Allen McClay OBE, CBE announces his retirement from Galen Holdings

2000

2000

Clinical Trial Supply business acquired from Duke University in Durham, NC, USA

2000

Galen acquires Warner Chilcott – restructure of organization to Galen Pharma and Galen Services

1999

1999

Purchase of ICTI later to become Almac Clinical Technologies

1997

Galen Ltd floated on the stock market to become Galen Holdings Plc – Northern Ireland’s first £ billion company

1996

1996

API Manufacturing and Chemical Development services established in Craigavon, UK

1996

1996

Expansion to the US with Clinical Trial Supply operations commences in Audubon, PA, USA

1988

Clinical Trial Supply operations commence in Craigavon, UK

1978

1978

Pharmaceutical Manufacturing commences in Craigavon, UK

1968

1968

Galen Ltd founded by Allen McClay

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies